Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 31 min ago
Peer-reviewedCC BYHealthcare (Basel, Switzerland)

Prevalence of Self-Reported Pelvic-Floor-Related Symptoms Among Female Patients with Multiple Sclerosis.

  1. 1Department of Physical Therapy and Rehabilitation Sciences, Applied Medical Sciences College, Majmaah University, Majmaah 11952, Saudi Arabia.

Abstract

Introduction: Multiple sclerosis (MS) is more prevalent among females worldwide. The Expanded Disability Status Scale (EDSS) assesses MS progression, including disability related to pelvic floor dysfunction (PFD), such as bowel and bladder dysfunction. However, data on PFD symptoms in patients with MS remain limited. Objective: To evaluate the prevalence and impact of self- reported pelvic-floor-related symptoms among women with MS in Saudi Arabia and their effects on quality of life (QOL). Methods: A cross-sectional study was conducted among 112 female patients with MS (EDSS ≤ 7, age ≥ 18 years). The participants completed two validated self-reported questionnaires, the Pelvic Floor Distress Inventory (PFDI-20) and the Pelvic Floor Impact Questionnaire (PFIQ-7), to assess self-reported pelvic-floor-related symptoms and their impact on QOL in women with MS. Results: The most commonly reported symptoms were frequent urination (83%), urge incontinence (70.5%), and constipation (76.8%). Following adjustment for multiple comparisons, increasing age was positively associated with greater urinary symptom distress, overall pelvic-floor-related symptom burden, and greater urinary and prolapse related impact on QOL. In the multivariable analysis, age remained significantly associated with total PFDI-20 scores after adjustment for BMI, MS duration, and marital status. BMI, MS diagnosis duration, and marital status were not significantly associated with total PFDI-20 or PFIQ-7 scores in the multivariable models. Conclusions: Women with MS reported a substantial burden of pelvic-floor-related symptoms, particularly urinary and colorectal anal symptoms, which were associated with adverse effects on physical activities and emotional well-being. These findings highlight the importance of recognizing and assessing pelvic-floor-related symptoms as part of comprehensive care for women with MS.

Related

  1. Digital signatures of fatigue and wearing-off symptoms in patients with multiple sclerosis under natalizumab
    Lars Masanneck, Elaine Trautmann, Judith von Pavel +13
    NeurotherapeuticsPeer-reviewedCC BYFull textNeurologyDOAJ
  2. Gluten-Free and Gluten-Restricted Diets in Multiple Sclerosis: A Systematic Review of Disease Activity and Patient-Reported Outcomes
    Rakan Alromayan, Reema Alshihri, Nora Aljohani +3
    NutrientsPeer-reviewedCC BYFull textNutritionEurope PMC
  3. Symptoms as Correlates of Health-Related Quality of Life in Black and White Individuals With Multiple Sclerosis
    Trinh L. T. Huynh, Brenda Jeng, Victoria Flores +3
    International Journal of MS CarePeer-reviewedLicence not statedFull textGeneral medicinePMC
  4. The Prevalence of Schizophrenia and Bipolar Disorder in Multiple Sclerosis: A Systematic Review and Meta-Analysis
    Imen Ketata, Feten Tabib, Marwa Abid +1
    International Journal of MS CarePeer-reviewedLicence not statedFull textGeneral medicinePMC
  5. Prevalence of self-reported dry eye symptoms after refractive surgery among Saudi adults: A cross-sectional survey
    Mahmood J Showail, Abubakr S Alzwaihri, Eid A Almasoudi +4
    PLOS OnePeer-reviewedCC BYFull textGeneral biologyEpidemiology & public healthPLOSEurope PMCPMC
BibTeX
@article{alqurashi2026prevalence,
  title = {{Prevalence of Self-Reported Pelvic-Floor-Related Symptoms Among Female Patients with Multiple Sclerosis.}},
  author = {Waad Alqurashi and Danah Alyahya},
  journal = {Healthcare (Basel, Switzerland)},
  year = {2026},
  month = oct,
  doi = {10.3390/healthcare14193324},
  url = {https://europepmc.org/article/MED/42881761},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Prevalence of Self-Reported Pelvic-Floor-Related Symptoms Among Female Patients with Multiple Sclerosis.
AU  - Waad Alqurashi
AU  - Danah Alyahya
PY  - 2026
DA  - 2026/10/06
JO  - Healthcare (Basel, Switzerland)
DO  - 10.3390/healthcare14193324
UR  - https://europepmc.org/article/MED/42881761
AB  - Introduction: Multiple sclerosis (MS) is more prevalent among females worldwide. The Expanded Disability Status Scale (EDSS) assesses MS progression, including disability related to pelvic floor dysfunction (PFD), such as bowel and bladder dysfunction. However, data on PFD symptoms in patients with MS remain limited. Objective: To evaluate the prevalence and impact of self- reported pelvic-floor-related symptoms among women with MS in Saudi Arabia and their effects on quality of life (QOL). Methods: A cross-sectional study was conducted among 112 female patients with MS (EDSS ≤ 7, age ≥ 18 years). The participants completed two validated self-reported questionnaires, the Pelvic Floor Distress Inventory (PFDI-20) and the Pelvic Floor Impact Questionnaire (PFIQ-7), to assess self-reported pelvic-floor-related symptoms and their impact on QOL in women with MS. Results: The most commonly reported symptoms were frequent urination (83%), urge incontinence (70.5%), and constipation (76.8%). Following adjustment for multiple comparisons, increasing age was positively associated with greater urinary symptom distress, overall pelvic-floor-related symptom burden, and greater urinary and prolapse related impact on QOL. In the multivariable analysis, age remained significantly associated with total PFDI-20 scores after adjustment for BMI, MS duration, and marital status. BMI, MS diagnosis duration, and marital status were not significantly associated with total PFDI-20 or PFIQ-7 scores in the multivariable models. Conclusions: Women with MS reported a substantial burden of pelvic-floor-related symptoms, particularly urinary and colorectal anal symptoms, which were associated with adverse effects on physical activities and emotional well-being. These findings highlight the importance of recognizing and assessing pelvic-floor-related symptoms as part of comprehensive care for women with MS.
SN  - 2227-9032
ER  -